[ Price : $8.95]
FDA says Tris Pharma has failed to comply with pediatric assessment requirements for its Nexiclon.[ Price : $8.95]
FDA grants Kinex Pharmaceuticals an orphan drug designation for KX02 for treating gliomas.[ Price : $8.95]
FDA releases its postmarket safety evaluations on nine drugs completed earlier this year.[ Price : $8.95]
FDA releases the FDA-483 from a March-April inspection at Meridian Medical Technologies.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on biological product deviations and human cells, tissue...[ Price : $8.95]
Teva asks FDA to require integrated dose counters in all new and already marketed metered-dose inhaler products.[ Price : $8.95]
Federal Register Notice: FDA sends a proposed collection of information on device third party review to the Office of Management a...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on human tissue intended for transplantation to the Offi...